When Immunotherapy Works Even With Low PD-L1 Expression
While PD-L1 testing is widely used to guide immunotherapy decisions, a low or negative PD-L1 result does not necessarily mean […]
Precision Oncology
Precision Oncology
The Role of PD-L1 Testing Before Starting Immunotherapy
PD-L1 testing is an important biomarker assessment used to guide the use of immunotherapy in several cancers, particularly lung cancer
Precision Oncology
What Is Biomarker-Driven Therapy in Modern Oncology?
Biomarker-driven therapy is a precision oncology approach where cancer treatment is selected based on specific molecular characteristics of a tumor
Precision Oncology
The Foundations of Precision Oncology in Modern Cancer Care
Precision oncology is a structured approach to cancer treatment that integrates tumor biology, molecular profiling, and patient-specific clinical factors to
Precision Oncology
How Molecular Profiling Influences Treatment Decisions in Lung Cancer
Molecular profiling in lung cancer identifies specific genetic alterations within a tumor that determine which therapy is most biologically appropriate.